Home Corporate Governance AGM Summary SEC Filings Financial Reports Stock Information Press Releases Event Calendar Analyst Coverage E-mail Alerts Investor Kit Information Request Contact IR Investor Relations Corporate Profile Simcere Pharmaceutical Group is a leading manufacturer and supplier of branded generic pharmaceuticals in the rapidly growing China market. Our strategic focus is to introduce first-to-market generic and innovative pharmaceuticals for the treatment of diseases with high incidence and/or mortality rate and for which there is a clear demand for more effective pharmacotherapy. We currently manufacture and sell 39 principal pharmaceutical products and are the exclusive distributor of three additi... More >> Stock Quote SCR (Common Stock) Exchange NYSE (US Dollar) Price $8.70 Change (%)   0.33 (3.65%) Volume 157,512 Data as of 07/02/09 4:17 p.m. ET Minimum 20 minute delay Refresh quote Featured Documents 2007 Annual Report   Recent Press Releases More >> Date Title   06/19/09 Simcere Pharmaceutical Group Files Annual Report on Form 20-F 05/26/09 Simcere Pharmaceutical Group Announces Agreement to Acquire 37.5% Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. 05/19/09 Simcere Pharmaceutical Group Appoints Dr. Peng Wang as Chief Scientific Officer 05/19/09 Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results Upcoming Events More >> There are currently no events scheduled. Receive E-mail Alerts Sign up to receive e-mail alerts whenever Simcere Pharmaceutical Group posts new information to the site. Just enter your e-mail address and click Submit. Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Copyright 2000- www.simcere.com/english All rights reserved. Tel. 86-25-85566666 fax 86-25-85471729 Design by 71nc.com